Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Abbvie Inc

Recent news which mentions Abbvie Inc

< Previous 1 2 Next >
Trump threatens to put up to 200% tariff on pharmaceuticals 'very soon'
Tags Johnson & Johnson Biotechnology Health care industry
From CNBC.com News
Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump's plan
Tags Business Politics Abbvie Inc
From CNBC.com News
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
Tags Gilead Sciences Inc Biontech SE Companies
From CNBC.com News
Jim Cramer suggests why it's hard to own traditional 'safety' stocks here
Tags Procter & Gamble Co Business News Investment Strategy
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags Biotechnology Business News Pharmaceuticals
From CNBC.com News
Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms
Tags Johnson & Johnson Health care industry Biotechnology
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags Amgen Inc Biotechnology Mergers
From CNBC.com News
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom
Tags GSK plc Health care industry Novartis AG
From CNBC.com News
Cramer's week ahead: Earnings from Tesla, Alphabet, Capital One and Boeing
Tags stocks Investment Strategy Agnico Eagle Mines Ltd
From CNBC.com News
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
Tags Johnson & Johnson Pfizer Inc AstraZeneca PLC
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Tags GSK plc Pro: Investing trends Bristol/Myers Squibb Co
From CNBC.com News
Ad spending on women's sports more than doubled last year
Tags Restaurant Brands International Inc Business News Women's sports
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Healthy Returns Health & Science LILLY DRN
From CNBC.com News
Cramer's Lighting Round: AbbVie is a buy
Tags Stock markets Cerence Inc Mad Money
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Pharmaceuticals Bristol/Myers Squibb Co US: News
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags GSK plc stocks Amgen Inc
From CNBC.com News
Cramer's Lightning Round: Sweetgreen is 'terrific'
Tags Abbvie Inc Clover Health Investments Corp S&P 500
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags Brown & Brown Inc Investment strategy Walgreens Boots Alliance Inc
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Business News US: News Bristol/Myers Squibb Co
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Tags Politics Abbvie Inc Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
Tags CVS Health Corp UnitedHealth Group Inc Health care industry
From CNBC.com News
AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
Tags Health care industry Biotechnology Pharmaceuticals
From CNBC.com News
After 8 months stuck in orbit, Varda's drug spacecraft gets FAA approval to return
Tags US: News Breaking News: Technology Business News
From CNBC.com News
Cramer's Lightning Round: AbbVie is 'a very good company'
Tags U/S/ Markets Market Outlook Investment strategy
From CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
Tags Moderna Inc Alvotech SA Johnson & Johnson
From CNBC.com News
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
Tags Ambrx Biopharma Inc Pfizer Inc Johnson & Johnson
From CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
Tags Markets Business JPMORGAN DRN
From CNBC.com News
Pfizer shares fall as 2024 revenue and profit forecast disappoints
Tags Earnings Health care industry Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags 5 Things to Know Investing JPMORGAN DRN
From CNBC.com News
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
Tags Abbvie Inc Business Biotech and Pharmaceuticals
From CNBC.com News
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.